Public
黑料正能量 Association content that is available to the public and all website users.
The Centers for Medicare & Medicaid Services (CMS) Dec. 1 issued a final rule that updates physician fee schedule (PFS) payments for calendar year (CY) 2021. The rule also adopts several policies to implement year five of the quality payment program (QPP) created by the Medicare Access and CHIP鈥
The Centers for Medicare & Medicaid Services Dec. 2 issued its calendar year (CY) 2021 outpatient prospective payment system (OPPS)/ambulatory surgical center (ASC) final rule. In addition to standard updates, the rule maintains previous payment cuts for certain drugs purchased under the 340B鈥
December 15, 2020
An open letter to all health care professionals:
Picture Archiving Communication Systems (PACS) are widely used by hospitals, research institutions, clinics and small healthcare practices for sharing patient data and medical images. In 2019, researchers disclosed a vulnerability in these systems that if exploited could potentially expose patient鈥
On December 13, 2020, FireEye and SolarWinds released security advisories detailing a highly-skilled and highly-targeted, manual supply chain attack on the SolarWinds Orion Platform network management system that leverages software updates to deploy a backdoor to victim organizations.
Last night, House and Senate Committee leaders announced a bipartisan agreement to address surprise medical bills, the 鈥淣o Surprises Act.鈥 The bill is supported by House Ways and Means Committee Chairman Richard E. Neal (D-MA) and Ranking Member Kevin Brady (R-TX), House Energy and Commerce鈥
The Food and Drug Administration late last night granted an emergency use authorization (EUA) to Pfizer, Inc. for its BNT162b2 mRNA COVID-19 vaccine, paving the way for its immediate administration across the country. Health care workers and nursing home residents will receive first priority and鈥
Hospitals and Pharmacists File Lawsuit over Drug Companies鈥 Refusals of 340B Discounts
Associations and Hospitals Motion for Preliminary Injunction Re: HHS Action to Address 340B Contract Pharmacy issue (Dec. 11, 2020)
The Food and Drug Administration today granted an emergency use authorization to Pfizer, Inc. for its BNT162b2 mRNA COVID-19 vaccine, paving the way for its immediate administration across the country. The vaccine is administered in two doses, 21 days apart, and requires ultracold (minus-70 degrees鈥